Class / Patent application number | Description | Number of patent applications / Date published |
424648000 | Ferrous | 22 |
20090136594 | Functionalization of Micro-And Nano Particles for Selective Attachment to Calcium Biomineral Surfaces - The present invention includes compositions, methods, devices and kits for magnetizing a biological particle by contacting a biological particle with a ferrous or magnetic particle that is able to specifically bind the biological particle and reacting the biological particle with the ferrous or magnetic particle under physiological conditions, wherein the ferrous or magnetic particle causes the biological particle to become attractable magnetically. | 05-28-2009 |
20090280191 | PREVENTIVE REMEDIAL THERAPEUTIC AGENT FOR PHOSPHORUS IMPAIRMENT, ORAL AGENT FOR ADSORBING PHOSPHATE ION CONTAINED IN FOOD, BEVERAGE AND CHEMICAL, AND PROCESS FOR PRODUCING THEM - The present invention provides agents for preventing, improving or treating phosphorus-related disorders and oral preparations; agents high in biosafety and phosphorus adsorptive power, which contain, as an active ingredient, ferric hydroxide as produced under such conditions that a ferrous species is present. | 11-12-2009 |
20090304816 | METHOD AND COMPOSITION FOR TREATING AND DIAGNOSING RESTLESS LEGS SYNDROME - A method of treating Restless Legs Syndrome (RLS) comprises the joint administration of an agent selected from dopamine turnover increasing agent and dopaminergic receptor exciting agent, in particular pramipexole, and iron in a biologically usable form, in pharmacologically effective combined amounts. Also disclosed is a corresponding use; a pharmaceutical composition comprising an agent selected from dopamine turnover increasing agent and dopaminergic receptor exciting agent, in particular pramipexole, and iron in a biologically usable form, and a pharmaceutically acceptable carrier; a package comprising a pharmaceutical composition for per-oral administration comprising an agent selected from dopamine turnover increasing agent and dopaminergic receptor exciting agent and a pharmaceutically acceptable carrier and a pharmaceutical composition for per-oral administration comprising iron in a biologically usable form and a pharmaceutical acceptable carrier. | 12-10-2009 |
20090317488 | Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof - A process for preparing a formulation comprising a complex comprising an effective amount of ferrous iron bound to a pharmaceutically acceptable cationic resin and at least one pharmaceutically acceptable carrier is described. Such a formulation may optionally include other desirable dietary supplements including, e.g., vitamins, omega fatty acids, and/or fluoride. The formulation is particularly well adapted for pediatric use, but is also useful for use in adult populations. | 12-24-2009 |
20100047367 | COMPOUNDS AND METHODS FOR THEIR USE - The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme. | 02-25-2010 |
20100303928 | ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS - The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme. | 12-02-2010 |
20100330199 | ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY | 12-30-2010 |
20110052722 | Toleration Iron Supplement Compositions - The invention relates to compositions and methods for the treatment or prophylaxis of iron deficiency, and in particular of iron deficiency anemia, by administering a composition containing an effective amount of a pharmaceutically acceptable ferrous iron salt; and an effective amount of polysaccharide iron complex. | 03-03-2011 |
20110183009 | Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity - The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered as monotherapy or in combination with one or more compounds, including psychostimulants, for the indication of ADHD and associated or co-morbid symptoms. | 07-28-2011 |
20110244057 | COMBINATION THERAPIES WITH TOPIRAMATE FOR SEIZURES, RESTLESS LEGS SYNDROME, AND OTHER NEUROLOGICAL CONDITIONS - The invention provides compositions and methods of treating various conditions, including neurological conditions, with pharmaceutical compositions including a sulfamate (e.g., topiramate) and magnesium. | 10-06-2011 |
20110305776 | THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS - The present invention relates to novel compounds, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). | 12-15-2011 |
20130011495 | ANTIFUNGAL COMPOUNDS AND USE THEREOF - The present invention relates to an antifungal composition including at least two compounds selected from among the group consisting of cysteine, salicylic acid, iron(II) sulfate and fosetyl-aluminum, as well as to a method for treating a plant, infected or not infected by a pathogen. Specifically, the present invention relates to an antifungal composition for treating vineyards. | 01-10-2013 |
20130108710 | Antimalarial Drug Which Contains 5-Aminolevulinic Acid or Derivative Thereof as Active Ingredient | 05-02-2013 |
20130209577 | Buffered Upper GI Absorption Promoter - The present invention relates to compositions of an active pharmaceutical compound or nutritional ingredient with one or more buffering agents between a pH of 1.0 and 6.0, preferably 2.0 and 4.0. The buffering agents are constituted to maintain or reduce the pH of the duodenal fluid in the proximal, mid and distal duodenum. The present invention further relates to methods of improving the absorption of an iron compound or an active pharmaceutical compound within the small intestine. The present compositions and methods improve absorption or bioavailability of the administered compositions. | 08-15-2013 |
20130230604 | ORAL IRON DEFICIENCY THERAPY - Methods of normalizing iron levels, treating iron deficiency and disorders related thereto, such as anemia, as described. Pharmaceutical compositions effective for such treatments are also described. | 09-05-2013 |
20130259954 | Liquid for Treatment of Citrus Greening Disease and Treatment Method Using Same - Provided are: a liquid for treatment of Citrus greening disease, which is capable of curing citrus trees with Citrus greening disease; and a treatment method using the liquid. The liquid for treatment of Citrus greening disease contains Fe ions and at least some of the Fe ions are present in the form of Fe | 10-03-2013 |
20130295197 | Formed lyocell articles for selective binding of monovalent heavy metal ions, especially thallium and cesium ions and radioactive isotopes thereof - Shaped lyocell cellulose articles are provided for binding heavy metal ions and radioactive isotopes thereof. The shaped articles include one or more hexacyanoferrates that are incorporated in a cellulosic matrix and uniformly distributed therein. The shaped articles can be fibers, fibrids, fibrous nonwoven webs, granules, beads, self-supporting films, tubular films, filaments, sponges, foams or bristles. They are useful for water treatment and water decontamination, for metal beneficiation, for treatment of wound with wound dressings, for air and gas filtration and in protective apparel. | 11-07-2013 |
20130323325 | COMPOSITION COMPRISING MIXED METAL COMPOUNDS AND XANTHAN GUM - The present invention provides a composition comprising (i) a mixed metal compound containing at least one trivalent metal selected from iron (lll) and aluminium and at least one divalent metal selected from of magnesium, iron, zinc, calcium, lanthanum and cerium, (ii) xanthan gum (iii) at least one of (a) polyvinyl pyrrolidone (b) locust bean gum (c) methyl cellulose wherein the composition has been irradiated with ionising radiation in an amount of at least 4 kGy. | 12-05-2013 |
20140186467 | COMPOSITION AND USE FOR ERADICATION OF HIV, TREATMENT OF AIDS AND OTHER DISEASES INCLUDING TUBERCULOSIS IN A HUMAN - A composition comprising at least one penicillin, at least one iron source, and at least one oil, method of making, and method of use thereof are described. Although suitable for many forms and uses, the composition is, in some embodiments, suitable as a pharmaceutical composition, and, in some embodiments, as an antiviral composition capable of restoring T cell count and eradicating HIV virus from patients suffering from HIV/AIDS and other diseases including Tuberculosis. | 07-03-2014 |
20150335758 | METHOD AND COMPOSITION FOR ALLEVIATING OR PREVENTING ISCHEMIC TISSUE DAMAGE - A method for increasing collateral circulation includes providing a pharmaceutically acceptable synthetic cerebrospinal fluid that has a density different than that of the patient's naturally-occurring cerebrospinal fluid. The synthetic cerebrospinal fluid includes a vasodilator. The method further includes administering the synthetic cerebrospinal fluid to an intrathecal space of a patient through a lumbar access point to reach the intrathecal space of a patient. | 11-26-2015 |
20160159796 | NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF HYPOXIA INDUCIBLE FACTOR (HIF) HYDROXYLASE - The present disclosure relates to novel compounds, methods, and compositions capable of inhibiting HIF hydroxylase enzyme activity, thereby increasing the stability and/or activity of hypoxia inducible factor (HIF). | 06-09-2016 |
20160166609 | IRON-BASED MONTMORILLONITE MEDICAMENT FOR TREATING HYPERPHOSPHATEMIA AND IRON-DEFICIENCY ANEMIA, AND PREPARATION METHOD THEREFOR | 06-16-2016 |